MedTrace Logo

Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation

NCT02864862 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2022-12-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.

Conditions

  • Dental Implant
  • Immediate Dental Implant
  • Soft Tissue Augmentation

Interventions

DEVICE

Immediate implant

BIOLOGICAL

SCTG

BIOLOGICAL

ADM

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Chun-Teh Lee, DDS, DMSc · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2021-11-22
Completion
2021-11-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864862 on ClinicalTrials.gov